153 related articles for article (PubMed ID: 18379686)
1. Crystal structure and silica condensing activities of silicatein alpha-cathepsin L chimeras.
Fairhead M; Johnson KA; Kowatz T; McMahon SA; Carter LG; Oke M; Liu H; Naismith JH; van der Walle CF
Chem Commun (Camb); 2008 Apr; (15):1765-7. PubMed ID: 18379686
[TBL] [Abstract][Full Text] [Related]
2. The alpha1/2 helical backbone of the prodomains defines the intrinsic inhibitory specificity in the cathepsin L-like cysteine protease subfamily.
Guo YL; Kurz U; Schultz JE; Lim CC; Wiederanders B; Schilling K
FEBS Lett; 2000 Mar; 469(2-3):203-7. PubMed ID: 10713271
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure of human cathepsin L complexed with E-64.
Fujishima A; Imai Y; Nomura T; Fujisawa Y; Yamamoto Y; Sugawara T
FEBS Lett; 1997 Apr; 407(1):47-50. PubMed ID: 9141479
[TBL] [Abstract][Full Text] [Related]
4. Human cathepsin X. A novel cysteine protease with unique specificity.
Ménard R; Nägler DK; Zhang R; Tam W; Sulea T; Purisima EO
Adv Exp Med Biol; 2000; 477():317-22. PubMed ID: 10849759
[No Abstract] [Full Text] [Related]
5. The heavy-light chain loop of human cathepsin-L modulates its activity and stability.
Fairhead M; van der Walle CF
Protein Pept Lett; 2008; 15(1):47-53. PubMed ID: 18221013
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of a cathepsin L-like cysteine protease by a chimeric propeptide-derived inhibitor.
Godat E; Chowdhury S; Lecaille F; Belghazi M; Purisima EO; Lalmanach G
Biochemistry; 2005 Aug; 44(31):10486-93. PubMed ID: 16060657
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cathepsin L by epoxysuccinyl peptides simultaneously addressing active-site and remote-site regions.
Schaschke N; Assfalg-Machleidt I; Machleidt W
Chembiochem; 2008 Jul; 9(11):1721-4. PubMed ID: 18551692
[No Abstract] [Full Text] [Related]
8. Homology modeling of Entamoeba histolytica cysteine proteinases reveals the basis for cathepsin L-like structure with cathepsin B-like specificity.
Brinen LS; Que X; McKerrow JH; Reed SL
Arch Med Res; 2000; 31(4 Suppl):S63-4. PubMed ID: 11070225
[No Abstract] [Full Text] [Related]
9. Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization.
Brömme D; Li Z; Barnes M; Mehler E
Biochemistry; 1999 Feb; 38(8):2377-85. PubMed ID: 10029531
[TBL] [Abstract][Full Text] [Related]
10. Human cathepsins W and F form a new subgroup of cathepsins that is evolutionary separated from the cathepsin B- and L-like cysteine proteases.
Wex T; Levy B; Wex H; Brömme D
Adv Exp Med Biol; 2000; 477():271-80. PubMed ID: 10849754
[No Abstract] [Full Text] [Related]
11. Elastin degradation by cathepsin V requires two exosites.
Du X; Chen NL; Wong A; Craik CS; Brömme D
J Biol Chem; 2013 Nov; 288(48):34871-81. PubMed ID: 24121514
[TBL] [Abstract][Full Text] [Related]
12. Efficient silica synthesis from tetra(glycerol)orthosilicate with cathepsin- and silicatein-like proteins.
Povarova NV; Barinov NA; Baranov MS; Markina NM; Varizhuk AM; Pozmogova GE; Klinov DV; Kozhemyako VB; Lukyanov KA
Sci Rep; 2018 Nov; 8(1):16759. PubMed ID: 30425281
[TBL] [Abstract][Full Text] [Related]
13. Silicatein alpha: cathepsin L-like protein in sponge biosilica.
Shimizu K; Cha J; Stucky GD; Morse DE
Proc Natl Acad Sci U S A; 1998 May; 95(11):6234-8. PubMed ID: 9600948
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human cathepsin X is a carboxymonopeptidase only: a comparison with cathepsins B and L.
Puzer L; Cotrin SS; Cezari MH; Hirata IY; Juliano MA; Stefe I; Turk D; Turk B; Juliano L; Carmona AK
Biol Chem; 2005 Nov; 386(11):1191-5. PubMed ID: 16307485
[TBL] [Abstract][Full Text] [Related]
15. Sequence, characterization and localization of a cysteine proteinase cathepsin L in Schistosoma mansoni.
Michel A; Ghoneim H; Resto M; Klinkert MQ; Kunz W
Mol Biochem Parasitol; 1995 Jul; 73(1-2):7-18. PubMed ID: 8577349
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.
Ljunggren A; Redzynia I; Alvarez-Fernandez M; Abrahamson M; Mort JS; Krupa JC; Jaskolski M; Bujacz G
J Mol Biol; 2007 Aug; 371(1):137-53. PubMed ID: 17561110
[TBL] [Abstract][Full Text] [Related]
17. Discovery of selective and nonpeptidic cathepsin S inhibitors.
Irie O; Ehara T; Iwasaki A; Yokokawa F; Sakaki J; Hirao H; Kanazawa T; Teno N; Horiuchi M; Umemura I; Gunji H; Masuya K; Hitomi Y; Iwasaki G; Nonomura K; Tanabe K; Fukaya H; Kosaka T; Snell CR; Hallett A
Bioorg Med Chem Lett; 2008 Jul; 18(14):3959-62. PubMed ID: 18572405
[TBL] [Abstract][Full Text] [Related]
18. Engineered staphylococcal protein A's IgG-binding domain with cathepsin L inhibitory activity.
Bratkovic T; Berlec A; Popovic T; Lunder M; Kreft S; Urleb U; Strukelj B
Biochem Biophys Res Commun; 2006 Oct; 349(1):449-53. PubMed ID: 16935262
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages.
Yasuda Y; Li Z; Greenbaum D; Bogyo M; Weber E; Brömme D
J Biol Chem; 2004 Aug; 279(35):36761-70. PubMed ID: 15192101
[TBL] [Abstract][Full Text] [Related]
20. Azepanone-based inhibitors of human cathepsin L.
Marquis RW; James I; Zeng J; Trout RE; Thompson S; Rahman A; Yamashita DS; Xie R; Ru Y; Gress CJ; Blake S; Lark MA; Hwang SM; Tomaszek T; Offen P; Head MS; Cummings MD; Veber DF
J Med Chem; 2005 Nov; 48(22):6870-8. PubMed ID: 16250645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
